DANHSON is a pharmaceutically-oriented holding company, established in Bulgaria in 2015, by professionals with long experience in the field. The core business is development, production and marketing of pharmaceutical products (RX and OTC), food supplements and cosmetics.Main markets are Russian Federation, CIS, and the Balkans. Continues investment in production capacities either through acquisition of well-respected and established companies, or through investment from green field, in combination with analytical and technological know-how, guarantees high-quality service to our clients.DANHSON has a certificate for registration of Integrated Management System for Quality and Food Safety that refers to ISO 9001:2015DANHSON keeps enriching its portfolio of medicinal products, dietary supplements and medical devices.Submitted for approval by BDA: more than 15 new products.In the process of development in 2019 : more than 20 products.Our main mission is to actively develop the production of innovative and highly effective medicines and food supplements.Being a socially responsible company, DANHSON keeps investing in the creation and expanding of its team.Leading specialists work at DANHSON in the pharmaceutical sphere, taking care to constantly renew and expand the product portfolio in compliance with market requirements.DANHSON employees are a team of people sharing the same view, i.e. to develop products helping people to enjoy excellent health, self confidence and quality of life.DANHSON is seeking to enlarge its presence worldwide and attract partners for its main activities.The major markets where DANHSON has successful presence with its products, are as follows:RussiaBulgariaBelarusUkraineCentral Asian countries: Kazakhstan, Kyrgyzstan, Uzbekistan, TajikistanCaucasus region countries: Georgia, Armenia, AzerbaijanBaltic region countries, etc.DANHSON has a representative offices in Kazakhstan and in Belarus